Heart failure & cardiomyopathies
Patients Report Increased Control and Decreased Impact of Heart Failure During Pulmonary Pressure-Guided Management
Authors' conclusion
Two-year follow up of the patient experience of PAP-guided therapy indicated that patients reported increased QoL, perceptions of control, device acceptability and continued remote monitoring over the 24 month follow-up.
Study context
- Population
- Class III HF patients with pulmonary artery pressure (PAP) monitoring (CardioMEMS)135 with 24-month questionnaires
- Participants
- 272 patients
Methodological detailssubgroup, questionnaire-based, General linear mixed model (n = 272); paired analysis of 24-month completers (n = 135)
- Subgroup
- Questionnaire-based
- General linear mixed model (n = 272); paired analysis of 24-month completers (n = 135)
Primary result
As reported in the abstract
Overall HF-related QoL score · baseline to 6 months, maintained through 2 years
- Quality of life (QoL) score at baseline
- 44.5 ± 24.0
- QoL score at 6 months
- 58.8 ± 25.2
- Improvement maintained through 2 years
- all P < 0.0001
Original publication
Patients Report Increased Control and Decreased Impact of Heart Failure During Pulmonary Pressure-Guided Management. ESC Heart Fail. Published 17 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →